Skip to Main Content

Paper Details

Identification of novel mutational drivers reveals oncogene dependencies in multiple myeloma.
Blood
290
2018
ATM, BRAF, CCND1, DIS3, FAM46C, FGFR3, HUWE1, IDH1, IDH2, IRF4, KLHL6, MAF, MM, MYC, PRKD2, PTPN11 Oncogene, PTPN11 Oncogene mutations, Patients, driver gene, driver genes, hyperdiploidy, multiple myeloma, myeloma, oncogene, patients, t(11;14, t(14, t(4;14, tumor, tumor suppressor, tumor suppressor gene
Author NameAffiliation
Konstantinos MavromatisCelgene Corporation
Fadi TowficCelgene Corporation
Daniel AuclairMultiple Myeloma Research Foundation
Jonathan J KeatsTranslational Genomics Research Institute
Alexander Keith StewartMayo Clinic
Sagar LonialWinship Cancer Institute, Emory University
Kenneth C AndersonDana-Farber Cancer Institute, Harvard Medical School
Kenneth C AndersonDana-Farber Cancer Institute, Harvard Medical School
  • 1 - 8

Datasets

Release 1.2